BRPI0514347A - composição de arabinogalactana-proteìna (agp) purificada - Google Patents

composição de arabinogalactana-proteìna (agp) purificada

Info

Publication number
BRPI0514347A
BRPI0514347A BRPI0514347-0A BRPI0514347A BRPI0514347A BR PI0514347 A BRPI0514347 A BR PI0514347A BR PI0514347 A BRPI0514347 A BR PI0514347A BR PI0514347 A BRPI0514347 A BR PI0514347A
Authority
BR
Brazil
Prior art keywords
agp
protein
composition
inhibition
purified
Prior art date
Application number
BRPI0514347-0A
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Vandita Srivastava
Sameer Shankar Walunj
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of BRPI0514347A publication Critical patent/BRPI0514347A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

COMPOSIçãO DE ARABINOGALACTANA-PROTEìNA (AGP) PURIFICADA é descrita uma composição de Arabinogalactana-Proteína (AGP) purificada isolada através de um método seletivo a partir das folhas e/ou troncos da planta Argemone mexicana. Também é descrita uma composição de Arabinogalactana-Proteína (AGP) purificada isolada a partir das folhas e/ou troncos da planta Argemone mexicana, que tem um ou mais dos seguintes efeitos: imunossupressão, inibição de linfoproliferação, modulação de citocina como inibição de IL-2; inibição de IFN-<sym>, ou indução de IL-10; inibição de proliferação de queratinócito, atividade queratolítica e atividade inibidora em teste de inchaço de orelha de camundongo (MEST).
BRPI0514347-0A 2004-09-01 2005-04-26 composição de arabinogalactana-proteìna (agp) purificada BRPI0514347A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/931,814 US7601368B2 (en) 2004-09-01 2004-09-01 Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
PCT/IN2005/000132 WO2006025068A1 (en) 2004-09-01 2005-04-26 A purified arabinogalactan-protein (agp) composition

Publications (1)

Publication Number Publication Date
BRPI0514347A true BRPI0514347A (pt) 2008-06-10

Family

ID=35943518

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514347-0A BRPI0514347A (pt) 2004-09-01 2005-04-26 composição de arabinogalactana-proteìna (agp) purificada

Country Status (19)

Country Link
US (4) US7601368B2 (pt)
EP (1) EP1789439B1 (pt)
JP (1) JP2008511613A (pt)
KR (1) KR20070059062A (pt)
CN (1) CN101044161A (pt)
AP (1) AP2007003929A0 (pt)
AT (1) ATE452142T1 (pt)
AU (1) AU2005278780A1 (pt)
BR (1) BRPI0514347A (pt)
CA (1) CA2577134A1 (pt)
DE (1) DE602005018375D1 (pt)
EA (1) EA012208B1 (pt)
IL (1) IL181230A0 (pt)
MX (1) MX2007002428A (pt)
NO (1) NO20071120L (pt)
TN (1) TNSN07079A1 (pt)
UA (1) UA86986C2 (pt)
WO (1) WO2006025068A1 (pt)
ZA (1) ZA200701311B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
FR2938192B1 (fr) 2008-11-07 2012-08-24 Expanscience Lab Nouvel actif anti-vergetures et compositions le comprenant
US20120128597A1 (en) * 2008-08-16 2012-05-24 Forschungszentrum Borstel Composition for prevention and treatment of allergic and/or inflammatory diseases
CA2797236C (en) * 2010-05-05 2017-10-17 Comvita New Zealand Limited Immunostimulatory compositions comprising a honey isolate and uses thereof
FR2975004B1 (fr) * 2011-05-13 2013-06-28 Expanscience Lab Nouvel actif anti-rougeurs et compositions cosmetiques le comprenant
ITMI20112216A1 (it) 2011-12-05 2013-06-06 Fond Salvatore Maugeri Clinic A Del Lavoro E Composizione comprendente un estratto di chelidonium majus e copaiba e il suo impiego per il trattamento di disfunzioni cutanee
WO2014190398A1 (en) * 2013-05-31 2014-12-04 The University Of Melbourne Inhibition of amyloid fibril formation
EP3176175B1 (en) 2015-12-01 2020-07-01 Ruhr-Universität Bochum Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
WO2017093276A1 (en) 2015-12-01 2017-06-08 Protectimmun Gmbh Method for synthetically producing arabinogalactan compounds derived from plants and uses of said compounds for the prophylaxis of allergic reactions
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液
CN108603115A (zh) 2016-02-12 2018-09-28 来姆有限公司 神经生长促进剂及其制造方法、内服剂、培养基用添加剂、细胞稀释液用添加剂、培养基、细胞稀释液、抗氧化剂及其制造方法、外用剂、以及伤口治疗剂及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818533A (en) * 1985-07-09 1989-04-04 Vipont Pharmaceutical, Inc. Production of high purity alkaloids
US5494671A (en) * 1990-08-27 1996-02-27 The United States Of America As Represented By The Department Of Health And Human Services C-terminally truncated dengue and Japanese encephalitis virus envelope proteins
JP3177642B2 (ja) * 1991-09-10 2001-06-18 ライオン株式会社 抗男性ホルモン剤
HK1046290B (zh) 1999-06-30 2005-08-12 天津赛诺制药有限公司 造血的阿拉伯半乳聚糖组合物
WO2003057133A2 (en) * 2002-01-10 2003-07-17 Lupin Limited Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders

Also Published As

Publication number Publication date
EP1789439B1 (en) 2009-12-16
UA86986C2 (ru) 2009-06-10
WO2006025068A8 (en) 2006-04-20
US20060045930A1 (en) 2006-03-02
CN101044161A (zh) 2007-09-26
WO2006025068A1 (en) 2006-03-09
NO20071120L (no) 2007-05-14
DE602005018375D1 (de) 2010-01-28
IL181230A0 (en) 2007-07-04
KR20070059062A (ko) 2007-06-11
US7601368B2 (en) 2009-10-13
EP1789439A1 (en) 2007-05-30
JP2008511613A (ja) 2008-04-17
EA200700532A1 (ru) 2007-08-31
US20090270330A1 (en) 2009-10-29
TNSN07079A1 (en) 2008-06-02
US20090264341A1 (en) 2009-10-22
MX2007002428A (es) 2007-05-11
EA012208B1 (ru) 2009-08-28
US20100330650A1 (en) 2010-12-30
ATE452142T1 (de) 2010-01-15
CA2577134A1 (en) 2006-03-09
AP2007003929A0 (en) 2007-02-28
ZA200701311B (en) 2009-08-26
AU2005278780A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
NO20071120L (no) En renset arabinogalaktan-protein (AGP) sammensetning.
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
HK47981A (en) Perfumed bodies of copolymers of ethylene and polar monomer
MXPA06000407A (es) Isomero c cci-779.
WO2003000038A3 (en) Compositions and methods for modulating plant development
NO20013003L (no) Kinolin-derivater
TNSN05007A1 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof.
NO992353D0 (no) Rensing av neurotrofiner
ATE372121T1 (de) Nicht fermentiertes gelanteil aus samenhülsen von psyllium
MX212260B (es) Composiciones de carbohidratos de planta como complementos dieteticos
DZ3265A1 (fr) Derives de 4,5-diaryl-3(2h)-furanone comme inhibiteurs de cyclo-oxygenase-2
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
AU2002331332A1 (en) Sulfonium salts as phtoinitiators for radiation curable systems
BRPI0508644A (pt) catalisador ácido sólido e método de utilizar o mesmo
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
MXPA05007727A (es) Pelicula permeable al vapor de humedad que incluye copolimero de etileno y articulos que incluyen la misma.
AU2003247279A1 (en) Furancarboxamides
DE602004028493D1 (de) Isochinolinon-kaliumkanalinhibitoren
DE60027127D1 (de) Verwendung von Polyaminosäurederivaten zur Behandlung von Seborrhoe und verwandten Hautstörungen
AU2003232775A1 (en) Oxathiincarboxamides
IL165808A0 (en) Low molecular weight k5-n,o-oversulfated polysaccharide process for the preparation thereof and pharmaceutical compositions containing the same
MXPA04001855A (es) Derivados de sistemas de indan-1-ol c2-sustituidos, metodos para la produccion de los mismos y su uso como medicamentos.
GB2441600A (en) A purified arabinogalactan-protein (AGP) composition.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.